FDA Investigator Andrea D Swingle

Andrea D Swingle has conducted inspections on 132 sites in 3 countries as of 11 Jun 2014. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
132
Last Inspection Date:
11 Jun 2014
Investigator Role:
FDA Investigator
Redica ID:
100003744
Countries of Inspections:
United States of America, Ukraine
FDA Investigators that have inspected at least one site in common with Andrea D Swingle:
Adam J Taylor, Adrianna G Vargo, Alanna L Mussawwir Bias, Amanda L Baskin, Amina Bashir, Amy S Graf, Andrace L Deyampert, Andrew H Paeng, Angel S Johnson, Antonio M Hampton, Ava M Bowman, Barbara A Rusin, Barbara D Bennett, Bei Y He, Benjamin J Smith, Bernard P Heidt, Brandi N Mcgrady, Brandon L Mariner, Brian J Mundo, Brian P Hendrickson, Brittany M Lowe, Byungja E Marciante, Calvin K Cook, Caroline H Le, Catherine V Quinlan, CDR Kimberly Y Martin, CDR Sean T Creighton, Charles E Frelix, Charles I Ann, Charles L Zhou, Charles M Spyr, Chelsea J Falkowski, Chelsea J Snider, Constantin Y Philopoulos, Corrine M Carter, Crystal M Young Lewis, Daniel J Gorski, Danny Tuntevski, David A Paterson, David L Duncan, Dawn C Olenjack, Debara R Reese, Debara Reese, Denise L Burosh, Denise M Visco, Investigator, Dennis E Guilfoyle, PhD, Dennis R Downer, Dina A Tallman, Donald C Obenhuber, PhD, Emest F Bizjak, Emily J Orban, Eric S Pittman, Eric Zhu, Erin M Miller, Erma Zaimova, Everard A Irish, Hans T Meyers, Helen B Ricalde, Hokenson, Ifueko Osemwota, James A Lane, James N Rench, Jean Blackston Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer L Sheehan, Jennifer R Johnson, Joie A Navarrete, Joseph A Piechocki, Joseph R Strelnik, Judith A Jankowski, Karen M Cooper, Karen M Montgomery (KMM), Kathleen B Swat, Kathryn G Brown, Kelley L Clark, Kimberly A Dux, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen F Kononen, Lauren E Sexton, Lauren Iacono Connors, PhD, Leigh Anne Myers, Lesley Maep Lutao, Lewis K Antwi, Linda S Jozefiak, Lisa M Bellows, Lisa P Oakes, Luella J Rossi, Maira P Brading, Margaret N Persich, Marianne Allen, Marlon K Turner, Martin K Yau, PhD, Matthew J Gretkierewicz, Meisha R Sampson, Meisha Waters, Melina Lrodriguez Upton, Mercy Oyugi, Michael F Skelly, PhD, Michael Shanks, MS, Michele L Forster, PhD, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Nancy L Neiger, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neali H Lucas, Patricia A Cochran, Patricia H Dlugosz, Patrick B Cummings, Patsy J Domingo, Qiao Y Bobo, Rafeeq A Habeeb, Rasha Bamieh, Raymond T Oji, Rebecca E Dombrowski, Robert D Tollefsen, Robert J Ham, Robert M Barbosa, Rohn R Robertson, Sam H Haidar, PhD, Sandra A Boyd, Sargum C Sood, Seongeun Cho (Julia), PhD, Shannon A Gregory, Sherri J Jackson, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stephanie Mangigian, MS/OSH, RN, Susan F Laska, MS, Susan M North, Susan P Bruederle, Suyang Qin, Talmane J Fisher, Tarsha T Mcclendon, Thomas J Arista, Thursaml, Thuy T Nguyen, LCDR, Tina M Pawlowski, Tonnie L Carter, Travis S Bradley, Uruaku A Obasi, Uttaniti Limchumroon (Tom), Vera M Anderson, Wayne E Seifert, William D Tingley, William R Brubaker, Xikui Chen (nmi), PhD, Yangmin Ning, Yumi J Hiramine

Andrea D Swingle's Documents

Publish Date Document Type Title
October, 2013 EIR Advanced Interventional Pain Ctr IRB - EIR, 2013-10-24
January, 2014 FDA 483 Francis W. Price, Jr., MD - Form 483, 2014-01-17
December, 2011 FDA 483 Kathy Miller, M.D. - Form 483, 2011-12-19
February, 2013 FDA 483 Response Institutional Review Board of Franciscan Health Lafayette - Form 483R, 2013-03-05
May, 2014 EIR Eli Lilly and Company - EIR, 2014-05-08
November, 2012 EIR Indiana Lions Eye Bank, Inc. (dbA VisionFirst Indiana Lions Eye Bank) - EIR, 2012-11-20
May, 2013 EIR CSL Plasma - EIR, 2013-05-22
September, 2013 EIR Ruemu Birhiray - EIR, 2013-09-05
December, 2010 FDA 483 Cook General BioTechnology, LLC - Form 483, 2010-12-20
July, 2013 FDA 483 Cook Incorporated - Form 483, 2013-07-30
July, 2010 FDA 483 American Red Cross Blood Svs. Indiana-Ohio Region - Form 483, 2010-07-21
January, 2012 FDA 483 Cook General BioTechnology, LLC - Form 483, 2012-01-12
October, 2013 FDA 483 Advanced Interventional Pain Ctr IRB - Form 483, 2013-10-24
February, 2013 FDA 483 Institutional Review Board of Franciscan Health Lafayette - Form 483, 2013-02-13
September, 2013 FDA 483 Ruemu Birhiray - Form 483, 2013-09-05
November, 2012 FDA 483 Indiana Lions Eye Bank, Inc. (dbA VisionFirst Indiana Lions Eye Bank) - Form 483, 2012-11-20
February, 2013 EIR Institutional Review Board of Franciscan Health Lafayette - EIR, 2013-02-13
May, 2013 FDA 483 CSL Plasma - Form 483, 2013-05-22
September, 2013 FDA 483 Response Ruemu Birhiray - Form 483R, 2013-09-22
October, 2013 FDA 483 Response Advanced Interventional Pain Ctr IRB - Form 483R, 2013-11-12
July, 2011 FDA 483 Maureen Cooper - Form 483, 2011-07-18
January, 2014 EIR Francis W. Price, Jr., MD - EIR, 2014-01-17
October, 2012 FDA 483 COVANCE BIOANALYTICAL SERVICES, LLC - Form 483, 2012-10-19

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more